Scott Powell, MD
Otolaryngology · Brandon, FLNPI 1447266820
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Optinose US, Inc. at 39.2% of the total. Reporting peaked in 2023 at $11,310 and has fallen 83.2% since, to $1,904 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $165.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$17K
- Neurent Medical Limited$12K
- Medical Device Business Services, Inc.$6K
- Aerin Medical Inc.$3K
- Acclarent, Inc$1K
- Intersect ENT, Inc.$696
- plus $3K from 25 others
Across 27 payments — averaging $4839.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurent Medical Limited$101K
- Aerin Medical Inc.$30K
What the payments were for
- Consulting fees$14,87535%
- Speaking & faculty fees$10,94026%
- Travel & lodging$7,78818%
- Food & beverage$8,58520%
- Education$340%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 48 | $16,552 |
| Neurent Medical Limited | 17 | $11,889 |
| Medical Device Business Services, Inc. | 5 | $5,502 |
| Aerin Medical Inc. | 18 | $3,035 |
| Acclarent, Inc | 46 | $1,206 |
| Intersect ENT, Inc. | 10 | $696 |
| GSK | 21 | $521 |
| Sanofi | 20 | $471 |
| Regeneron Healthcare Solutions, Inc. | 13 | $470 |
| Stryker | 9 | $465 |
| Medtronic(2 entities) | 5 | $327 |
| Inspire Medical Systems, Inc. | 1 | $158 |
| Alk-abello, Inc | 3 | $133 |
| KARL Storz Endoscopy-america | 3 | $124 |
| Integra Lifesciences Corporation | 6 | $116 |
| Kaleo, Inc. | 5 | $74 |
| Amgen | 3 | $63 |
| Lucid Diagnostics Inc. | 3 | $62 |
| AstraZeneca | 3 | $52 |
| Hikma Pharmaceuticals USA | 3 | $51 |
| Novartis | 2 | $50 |
| Itamar Medical Inc | 1 | $38 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Circassia Inc. | 1 | $24 |
| Smith+Nephew | 1 | $18 |
| Merck | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Watermark Medical, Inc. | 1 | $12 |
| Glenmark Therapeutics Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$15,751
- NEUROMARK Radiofrequency Console$11,596
- NEUROMARK Device$10,673
- VIVAER STYLUS$2,488
- RHINAER STYLUS$2,488
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$1,040
- NEUROMARK System$923
- TruDi Navigation System$829
- TruDi Nav Suction$829
- TruDi Nav Cable$829
- PROPEL$221
- STEALTH AUTOGUIDE SYSTEM$196
- Vivaer RF Stylus$163
- Inspire Upper Airway Stimulation System$158
- ENTELLUS - XPRESS ENT DILATION SYSTEM$149
- SINUVA$147
- XPRESS ENT DILATION SYSTEM$125
- FIAGON NAVIGATION UNIT$125
- TruDi$124
- VivAer$118
How this compares
$42,226 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 27 | $108,024 |
| Epinephrine | 64 | $10,750 |
| XhanceFluticasone Propionate | 12 | $7,819 |
| Ipratropium Bromide | 156 | $3,609 |
| Azelastine Hcl | 67 | $2,490 |
| Fluticasone Propionate | 193 | $2,483 |
| Mometasone Furoate | 18 | $2,268 |
| Montelukast Sodium | 132 | $992 |
| Fluocinolone Acetonide Oil | 27 | $792 |
| Pantoprazole Sodium | 108 | $647 |
| Methylprednisolone | 62 | $384 |
| Rabeprazole Sodium | 13 | $328 |
| Celecoxib | 19 | $281 |
| Doxycycline Hyclate | 25 | $219 |
| Mupirocin | 29 | $162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $51 | $10,75064 claims |
| Optinose US, Inc.Xhance | $16,552 | $7,81912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 586 otolaryngology providers in Florida.
Other otolaryngology in Brandon
- Keith BaslerBrandon$11K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- David BrodnerBoynton Beach$209K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Indranil DebnathWinter Park$109K
- Agustin ArrietaMiami$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.